JAYKAY ENTERPRISES
|
JAYKAY ENTERPRISES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 1.47 | 1.35 | 3.57 | 5.98 | -0.14 |
| CEPS(Rs) | 1.19 | 1.06 | 2.11 | 3.40 | -0.07 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 30.66 | 25.96 | 24.39 | 22.22 | 15.78 |
| Tax Rate(%) | 6.41 | 25.22 | 3.54 | - | - |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 7.39 | 4.77 | -11.80 | -1,589.42 | -1,783.87 |
| EBIT Margin(%) | 27.87 | 25.79 | 172.06 | 8,458.41 | -173.67 |
| Pre Tax Margin(%) | 19.48 | 23.54 | 170.31 | 8,448.41 | -173.67 |
| PAT Margin (%) | 18.23 | 17.61 | 164.28 | 8,448.41 | -173.67 |
| Cash Profit Margin (%) | 23.37 | 20.98 | 165.97 | 8,482.31 | -141.71 |
| Performance Ratios | |||||
| ROA(%) | 3.81 | 4.90 | 14.97 | 31.39 | -0.81 |
| ROE(%) | 6.09 | 6.55 | 16.53 | 33.52 | -0.85 |
| ROCE(%) | 7.15 | 8.22 | 16.58 | 33.08 | -0.85 |
| Asset Turnover(x) | 0.21 | 0.28 | 0.09 | - | - |
| Sales/Fixed Asset(x) | 0.79 | 2.51 | 1.38 | 0.06 | 0.11 |
| Working Capital/Sales(x) | 0.61 | 0.54 | 0.25 | 0.01 | 0.01 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.26 | 0.40 | 0.72 | 17.14 | 9.38 |
| Receivable days | 356.17 | 232.01 | 222.85 | - | - |
| Inventory Days | 70.65 | 5.67 | 8.77 | 304.66 | 304.63 |
| Payable days | 185.17 | 119.80 | 45.99 | - | - |
| Valuation Parameters | |||||
| PER(x) | 45.22 | 18.58 | 16.93 | 6.32 | - |
| PCE(x) | 55.76 | 23.59 | 16.21 | 6.29 | -25.01 |
| Price/Book(x) | 3.83 | 1.71 | 2.48 | 1.70 | 0.19 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 13.84 | 4.60 | 23.44 | 392.47 | -53.63 |
| EV/Core EBITDA(x) | 40.80 | 15.51 | 87.59 | 7.37 | 37.85 |
| EV/EBIT(x) | 49.67 | 17.85 | 13.63 | 4.64 | 30.88 |
| EV/CE(x) | 3.05 | 1.26 | 2.04 | 1.22 | -0.28 |
| M Cap / Sales | 13.03 | 4.95 | 26.91 | 533.93 | 35.45 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 12.15 | 338.77 | 3,374.51 | - | 0.65 |
| Core EBITDA Growth(%) | 28.15 | 386.72 | -82.53 | 3,856.04 | -115.32 |
| EBIT Growth(%) | 21.18 | -34.22 | -29.32 | 4,970.47 | -119.39 |
| PAT Growth(%) | 16.11 | -52.98 | -32.44 | 4,964.62 | -121.05 |
| EPS Growth(%) | 8.90 | -62.21 | -40.27 | 4,253.59 | -121.04 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.33 | 0.19 | 0.05 | - | - |
| Current Ratio(x) | 2.51 | 2.80 | 4.56 | 14.19 | 8.51 |
| Quick Ratio(x) | 2.18 | 2.77 | 4.54 | 14.12 | 8.44 |
| Interest Cover(x) | 3.32 | 11.46 | 98.36 | 845.84 | - |
| Total Debt/Mcap(x) | 0.09 | 0.11 | 0.02 | - | - |
Compare Financial Ratios of peers of JAYKAY ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAYKAY ENTERPRISES | ₹1,417.4 Cr | 0.2% | -3.4% | 173.7% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹36,673.1 Cr | 7.2% | 3.7% | 23.9% | Stock Analytics | |
| JUST DIAL | ₹9,474.8 Cr | 3.6% | -1.7% | 56.8% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹9,183.4 Cr | -0.4% | 0.7% | -4.2% | Stock Analytics | |
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,873.4 Cr | 8% | 2% | -19.6% | Stock Analytics | |
| DREAMFOLKS SERVICES | ₹2,218.8 Cr | -2% | -4.4% | -25.4% | Stock Analytics | |
JAYKAY ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAYKAY ENTERPRISES | 0.2% |
-3.4% |
173.7% |
| SENSEX | 3.5% |
-0.1% |
21.9% |
You may also like the below Video Courses
